You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
华森制药(002907.SZ):子公司获得《药品GSP认证证书》和《药品经营许可证》
格隆汇 08-28 17:15

格隆汇8月28日丨华森制药(002907.SZ)宣布,公司全资子公司重庆华森医药有限公司(“华森医药”)于2019年8月28日收到重庆市药品监督管理局颁发的《药品经营质量管理规范认证证书》(“《药品GSP认证证书》”)和《药品经营许可证》。

其中《药品GSP认证证书》:证书编号CQ24-Aa-20190818;认证范围包括化学原料药及其制剂、抗生素原料药及其制剂、生化药品、中成药、中药材、中药饮片、生物制品、蛋白同化制剂、肽类激素、第二类精神药品;有效期至2024年8月19日。

《药品经营许可证》:证书编号渝AA0230993;经营范围包括化学原料药及其制剂、抗生素原料药及其制剂、生化药品、中成药、中药材、中药饮片、生物制品、蛋白同化制剂、肽类激素、第二类精神药品;有效期至2024年8月19日。

此次华森医药取得《药品GSP认证证书》和《药品经营许可证》,为原《药品GSP认证证书》(证书编号:CQ24-Aa-20140029)和《药品经营许可证》(渝AA2400343)到期后的再认证,不会对公司当前经营产生重大影响。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account